Literature DB >> 25039604

Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.

Stefan Blum1, Pamela A McCombe.   

Abstract

Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are thought to be autoimmune diseases. There have been many attempts to find a human leukocyte antigen (HLA) association with GBS and CIDP with little success. There have been studies of other plausible genes in GBS and CIDP and the role of these genes in GBS and CIDP and the data from these genetic studies is reviewed. Some of the genes that have been studied are immune related and some others have nervous system effects. The studies are limited by small numbers. Some of the genes show association with disease severity rather than disease susceptibility. The need for more detailed molecular studies of the role of HLA molecules and the need for modern genetic approaches to GBS and CIDP are explained.
© 2014 Peripheral Nerve Society.

Entities:  

Keywords:  CD1; Guillain-Barré syndrome; TNF; chronic inflammatory demyelinating polyradiculoneuropathy; disease associations; genetics; major histocompatability complex

Mesh:

Substances:

Year:  2014        PMID: 25039604     DOI: 10.1111/jns5.12074

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  15 in total

Review 1.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

Review 2.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

Review 3.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

4.  Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  S Buttini; G Cappellano; P Ripellino; C Briani; D Cocito; M Osio; R Cantello; U Dianzani; C Comi
Journal:  Genes Immun       Date:  2014-10-30       Impact factor: 2.676

Review 5.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 6.  Guillain-Barré syndrome in Colombia: where do we stand now?

Authors:  María P Mahecha; Ernesto Ojeda; Daniel A Vega; Juan C Sarmiento-Monroy; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

7.  Early predictors of Guillain-Barré syndrome in the life course of women.

Authors:  Nathalie Auger; Caroline Quach; Jessica Healy-Profitós; Trish Dinh; Michaël Chassé
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

Review 8.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

9.  Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.

Authors:  Laura Martinez-Martinez; Ma Cinta Lleixà; Gemma Boera-Carnicero; Andrea Cortese; Jérôme Devaux; Ana Siles; Yusuf Rajabally; Alicia Martinez-Piñeiro; Alejandra Carvajal; Julio Pardo; Emilien Delmont; Shahram Attarian; Jordi Diaz-Manera; Ilaria Callegari; Enrico Marchioni; Diego Franciotta; Luana Benedetti; Guiseppe Lauria; Oscar de la Calle Martin; Cándido Juárez; Isabel Illa; Luis Querol
Journal:  J Neuroinflammation       Date:  2017-11-16       Impact factor: 8.322

10.  Inflammatory demyelinating neuropathies with focal segmental glomerulosclerosis: Two case reports.

Authors:  Yuhe Mao; Min Zhang; Shaojun Liu; Yunyu Xu; Jun Xue; Chuanming Hao; Lingyun Lai
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.